熱門資訊> 正文

Zimmer Biomet完成对Monogram Technologies的收购

2025-10-07 22:23

Zimmer Biomet (NYSE:ZBH) has completed its $177M acquisition of Monogram Technologies (NASDAQ:MGRM), which was announced in July.
The acquisition provides Zimmer Biomet with Monogram's AI-driven, surgeon-guided, next-generation orthopedic robotics.
Terms of the deal have Monogram shareholders receiving $4.04 per share in cash, as well as up to $12.37 per share of common stock in cash if certain product development, regulatory, and revenue milestones are achieved through 2030.

More on Zimmer Biomet

Zimmer Biomet Holdings, Inc. (ZBH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Zimmer Biomet Holdings, Inc. (ZBH) Q2 2025 Earnings Call Transcript
Zimmer Biomet Q2 Preview: Combining Monogram Autonomous Robotics With ROSA
Zimmer Biomet Non-GAAP EPS of $2.07 beats by $0.09, revenue of $2.08B beats by $20M
Zimmer Biomet Q2 2025 Earnings Preview

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。